STA Pharmaceutical to open new transition metal catalysis center
STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China. The new state-of-the-art facility will allow STA to carry out rapid screening of metal catalysts, ligands, bases, acids, chemical resolving reagents, and amide formation coupling reagents, etc. The screening kits will enable high-throughput screening of metal catalysts and ligands for C-C, C-N, C-O and C-S formation reactions, as well as many other types of reactions such as chemical resolution and amide formation. The technology allows the STA team to more rapidly find the optimal catalysts using a parallel interactive testing approach.
A team of scientists specialized in this technology are currently being trained in the company’s Shanghai R&D center, and, once the new center becomes fully operational in early November, will move to the Changzhou site.
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.